These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30405792)

  • 1. Low expression of miR-199 in hepatocellular carcinoma contributes to tumor cell hyper-proliferation by negatively suppressing XBP1.
    Lou Z; Gong YQ; Zhou X; Hu GH
    Oncol Lett; 2018 Nov; 16(5):6531-6539. PubMed ID: 30405792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR; Feng JL; Liu XJ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
    Qin AD; Liu XX; Li J; Liu J; Li YS
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.
    Zhao L; Wang Y; Liu Q
    Exp Mol Pathol; 2019 Aug; 109():51-60. PubMed ID: 31145886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line.
    Zhao G; Han C; Zhang Z; Wang L; Xu J
    Biochem Biophys Res Commun; 2017 Aug; 490(2):371-377. PubMed ID: 28623129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-29 family functions as a tumor suppressor by targeting RPS15A and regulating cell cycle in hepatocellular carcinoma.
    Zhang NS; Dai GL; Liu SJ
    Int J Clin Exp Pathol; 2017; 10(7):8031-8042. PubMed ID: 31966655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [miR-128a is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation by targeting RND3].
    Guo X; Cao C; Sun J; Zhang D; Liu L; Wu D
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Oct; 34(10):1408-13. PubMed ID: 25345933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MicroRNA-30a inhibits proliferation of hepatocellular carcinoma cells via targeted regulation of forkhead-box protein A1].
    Li Y; Fu L; Fu XY; Li RH; Peng SF
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):706-711. PubMed ID: 29108194
    [No Abstract]   [Full Text] [Related]  

  • 13. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
    Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H
    Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.
    Cheng D; Deng J; Zhang B; He X; Meng Z; Li G; Ye H; Zheng S; Wei L; Deng X; Chen R; Zhou J
    EBioMedicine; 2018 Oct; 36():159-170. PubMed ID: 30195653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
    He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
    Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway.
    Zhang JJ; Chen JT; Hua L; Yao KH; Wang CY
    Biomed Pharmacother; 2017 Jan; 85():472-478. PubMed ID: 27890434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
    Tan W; Lim SG; Tan TM
    World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-204-5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expression.
    Chu Y; Jiang M; Du F; Chen D; Ye T; Xu B; Li X; Wang W; Qiu Z; Liu H; Nie Y; Liang J; Fan D
    FEBS Open Bio; 2018 Feb; 8(2):189-200. PubMed ID: 29435409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
    Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X
    Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
    Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
    Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.